NBI-1117570

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-1117570, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia [Phase 2]